T1	Participants 711 796	156 patients with stage III or IV gastric cancer who had undergone curative resection
T2	Participants 1697 1829	gastric cancer patients after curative gastrectomy; in particular, in patients with pT2/T3 tumors and intestinal-type primary tumors
